feed,title,long_url,short_url
SeekingAlpha,"SYN, TRXC, JAGX and BNGO among midday movers",https://seekingalpha.com/news/3648921,
SeekingAlpha,Inhibrx reports data from dose escalation part of early-stage INBRX-106 trial in solid tumors,https://seekingalpha.com/news/3648920,
